The promise of stem cells to treat cardiovascular disease may soon be a step closer to overcoming the last big hurdle before trials in human patients.
Su-Chun Zhang and co-first authors Yuejun Chen and Man Xiong grew the specialized nerve cells from human embryonic stem cells.
The exploratory analysis may open a new window on understanding complex disorders like autism.
If replicated in human cells, the feat could one day fuel drug discovery, powerful new models for heart disease and the raw material for treating diseased hearts.
When the body has a low blood cell count, it can have trouble fighting off infection. But transfusible blood products may be in the not-so-distant future.